Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ENZN > SEC Filings for ENZN > Form 8-K on 19-May-2014All Recent SEC Filings

Show all filings for ENZON PHARMACEUTICALS INC

Form 8-K for ENZON PHARMACEUTICALS INC


19-May-2014

Other Events


Item 8.01. Other Events.

Enzon Pharmaceuticals, Inc. (the "Company") has determined that it will submit, at next year's 2015 annual meeting of stockholders, the Company's Section 382 rights plan (the "Section 382 Rights Plan") to a binding vote by the Company's stockholders for ratification. As previously disclosed, the Section 382 Rights Plan was adopted by the Company's Board of Directors on April 30, 2014 in an effort to protect stockholder value by attempting to protect against a possible limitation on the Company's ability to use its net operating loss carryforwards. Additional information regarding the Section 382 Rights Plan is contained in the Company's Current Report on Form 8-K and the Company's Registration Statement on Form 8-A filed with the Securities and Exchange Commission (the "SEC") on May 1, 2014.

Participants in the Solicitation and Additional Information

The Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies from stockholders in connection with the Company's upcoming 2014 annual meeting of stockholders to be held on May 28, 2014. The Company has filed a definitive proxy statement with the SEC in connection with the solicitation of proxies for the 2014 annual meeting of stockholders, which was filed with the SEC on April 16, 2014 and may be obtained free of charge from the SEC's website at http://www.sec.gov or the Company's website at http://www.enzon.com. Stockholders are urged to read the definitive proxy statement because it contains important information. Information concerning the names of the Company's directors and executive officers and their respective interests in the Company by security holdings or otherwise is set forth in the definitive proxy statement.

  Add ENZN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ENZN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.